Credo Diagnostics Biomedical’s Post

Aptitude Secures $10M+ to Accelerate Development of Point-of-Care and Over-the-Counter CT/NG/TV STI Test on Metrix® Platform https://lnkd.in/gz8Gng7M SANTA BARBARA, Calif., Jan. 6, 2025 /PRNewswire/ — Aptitude Medical Systems, Inc. (Aptitude) has secured funding from the Bill & Melinda Gates Foundation to accelerate the development and release of its new Point of Care [...]

🔬 Breaking: FDA Approves Boston Scientific's Revolutionary Cardiac Device TL;DR: Boston Scientific secures FDA approval for their navigation-equipped pulsed field ablation catheter, advancing atrial fibrillation treatment. 🔍 Key Development: This grounddevice offers a minimally invasive approach to treating atrial fibrillation, combining precision navigation with innovative ablation technology. 💡 Industry Impact: - Sets new standards in cardiac care - Validates market demand for minimally invasive solutions - Demonstrates successful regulatory navigation in advanced medical tech 📋 Strategic Takeaways for Biotech Leaders: 1. Prioritize R&D in precision-driven treatments 2. Explore partnerships in electrophysiology tech 3. Strengthen regulatory compliance strategies What's your take on this advancement in cardiac care? Are you seeing similar innovations in your area of focus? Share your thoughts below. #BiotechInnovation #MedicalDevice #FDA #Healthcare #CardiacCare #pharma #biotech #medicinetomarket

Cast your vote for the Best New Clinical Diagnostics Kit or Assay of 2023 and the Best New Clinical Diagnostics Instrumentation of 2023. Which products do you think significantly advanced laboratory efforts in 2023? Vote here: https://lnkd.in/e3CnXH8p #scientistschoiceawards #clinicaldiagnostics #clinicalscience

Discover how Drucker Diagnostics and NXP are engineering the next generation of clinical benchtop centrifuges to ensure safer and healthier outcomes for everyone. 🚀🔬

There is growing interest in 3D ex vivo patient tissue as a platform that can improve assessment of drug candidates. We have compiled the top 10 questions and present these along with answers in our recent blog post. Topics covered include details on samples, platform application, turn-around time, and co-cultures. Get the answers you need ➡️ https://hubs.la/Q02Qrb_40

Today we published the results of our proof of principle study with BioReBone. The conclusion of this study was: Within the limitations of the current clinical trial, we found that ErhBMP-2/BioCaP/β-TCP could be considered as an osteopromotive and biocompatible bone substitute. This novel bone substitute can potentially achieve safe and effective treatment for repairing bone defects. The product has been developed in full compliance with the current international standards for the development of medical devices. If you are interested in more information do not hesitate to contact me. file:///Users/Herman/Downloads/J%20Clinic%20Periodontology%20-%202024%20-%20Wei%20-%20The%20Clinical%20Efficacy%20and%20Safety%20of%20ErhBMP%E2%80%902%20BioCaP%20%20%E2%80%90TCP%20as%20a%20Novel%20Bone%20Substitute.pdf

Because health matters:

💰 Edwards Lifesciences to acquire Innovalve Bio Medical Ltd. Combined with Edwards Lifesciences’ existing mitral innovations, the acquisition enhances the company’s TMVR technologies to address large unmet structural heart patient needs and support sustainable long-term growth. Innovalve Bio Medical Ltd. will join the transcatheter mitral and tricuspid therapies (TMTT) product group, led by corporate vice president, Daveen Chopra. Edwards Lifesciences is developing a portfolio of transcatheter repair and replacement therapies designed to address mitral and tricuspid valve diseases. Read more online: https://lnkd.in/geN-TSZc 📰 Follow Medical Device Developments to receive the latest medical device news daily and to subscribe to our weekly newsletter #MedicalDeviceDevelopments #medicaldevices #medicalmanufacturing

Gain insights into the intricate disparities between In Vitro Diagnostics and conventional medical devices, and how these differences influence development approaches. Are you confident in distinguishing between the regulatory pathways for your product? Let's spark a discussion in the comments! Blog Link: https://lnkd.in/g6VzhBgp #IVD #MedicalDevices #RegulatoryFramework #HealthcareInnovation #Nectar #MedTechInnovation360

'CDx Market Access: The Path to Precision Medicine Success,' reveals the key strategies for commercializing companion diagnostics. Don't miss out on this valuable resource. Download the white paper today! https://lnkd.in/gEr5fTzJ #CompanionDiagnostics #CDx #PrecisionMedicine #WhitepaperWednesday